Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 10

    1.

    Superior preservation of DCD livers with continuous normothermic perfusion.

    Fondevila C, Hessheimer AJ, Maathuis MH, Muñoz J, Taurá P, Calatayud D, Leuvenink H, Rimola A, Ploeg RJ, García-Valdecasas JC.

    Ann Surg. 2011 Dec;254(6):1000-7.

    PMID:
    21862925
    [PubMed - indexed for MEDLINE]
    2.

    Anatomy of the right liver lobe: a surgical analysis in 124 consecutive living donors.

    Bageacu S, Abdelaal A, Ficarelli S, Elmeteini M, Boillot O.

    Clin Transplant. 2011 Jul-Aug;25(4):E447-54. doi: 10.1111/j.1399-0012.2011.01466.x. Epub 2011 Apr 26.

    PMID:
    21518003
    [PubMed - indexed for MEDLINE]
    3.

    Guidelines for liver transplantation for patients with non-alcoholic steatohepatitis.

    Newsome PN, Allison ME, Andrews PA, Auzinger G, Day CP, Ferguson JW, Henriksen PA, Hubscher SG, Manley H, McKiernan PJ, Millson C, Mirza D, Neuberger JM, Oben J, Pollard S, Simpson KJ, Thorburn D, Tomlinson JW, Wyatt JS; British Transplant Society.

    Gut. 2012 Apr;61(4):484-500. Epub 2012 Jan 10. No abstract available.

    PMID:
    22234978
    [PubMed - indexed for MEDLINE]
    4.

    Systemic immunoregulatory and proteogenomic effects of tacrolimus to sirolimus conversion in liver transplant recipients.

    Levitsky J, Mathew JM, Abecassis M, Tambur A, Leventhal J, Chandrasekaran D, Herrera N, Al-Saden P, Gallon L, Abdul-Nabi A, Yang GY, Kurian SM, Salomon DR, Miller J.

    Hepatology. 2012 Jan 11. doi: 10.1002/hep.25579. [Epub ahead of print]

    PMID:
    22234876
    [PubMed - as supplied by publisher]
    5.

    Circulating microRNAs as potential markers of human drug-induced liver injury.

    Starkey Lewis PJ, Dear J, Platt V, Simpson KJ, Craig DG, Antoine DJ, French NS, Dhaun N, Webb DJ, Costello EM, Neoptolemos JP, Moggs J, Goldring CE, Park BK.

    Hepatology. 2011 Nov;54(5):1767-76. doi: 10.1002/hep.24538.

    PMID:
    22045675
    [PubMed - indexed for MEDLINE]
    6.

    Predicting clinical outcomes using baseline and follow-up laboratory data from the hepatitis C long-term treatment against cirrhosis trial.

    Ghany MG, Kim HY, Stoddard A, Wright EC, Seeff LB, Lok AS; HALT-C Trial Group.

    Hepatology. 2011 Nov;54(5):1527-37. doi: 10.1002/hep.24550.

    PMID:
    22045670
    [PubMed - indexed for MEDLINE]
    7.

    Nutritional considerations in end-stage liver disease.

    Strasser SI, Vidot H.

    J Gastroenterol Hepatol. 2011 Sep;26(9):1346-8. doi: 10.1111/j.1440-1746.2011.06830.x. No abstract available.

    PMID:
    21884244
    [PubMed - indexed for MEDLINE]
    8.

    Bile duct stenting in liver transplantation.

    Sibulesky L, Taner CB, Perry DK, Willingham DL, Nguyen JH.

    Transpl Int. 2012 Mar;25(3):e45-6. doi: 10.1111/j.1432-2277.2011.01421.x. Epub 2012 Jan 10. No abstract available.

    PMID:
    22233330
    [PubMed - in process]
    9.

    Association between vitamin D receptor genetic polymorphisms and acute cellular rejection in liver-transplanted patients.

    Falleti E, Bitetto D, Fabris C, Cmet S, Fornasiere E, Cussigh A, Fontanini E, Avellini C, Barbina G, Ceriani E, Pirisi M, Toniutto P.

    Transpl Int. 2012 Mar;25(3):314-22. doi: 10.1111/j.1432-2277.2011.01419.x. Epub 2012 Jan 3.

    PMID:
    22220717
    [PubMed - in process]
    10.

    Calcium channel blockers or angiotensin-converting enzyme inhibitors for de novo hypertension after liver transplant: and the winner is …?

    Carbone M, Sagar V, Ferguson J, Neuberger J.

    Transplantation. 2012 Jan 27;93(2):e2-4. No abstract available.

    PMID:
    22234315
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk